CINDI BEANLAND: Open Payments
NPI 1841908647 · ESSEX, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 44 payments from 18 companies in 2025. Trend: 2023 $2,016 · 2024 $1,644 · 2025 $870
Food & beverage: $801Education: $69
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $173 |
| Astellas Pharma US Inc | 2 | $83 |
| ABBVIE INC. | 4 | $76 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Lilly USA, LLC | 4 | $65 |
| PFIZER INC. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Amgen Inc. | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $36 |
Products named: Ozempic, VRAYLAR, ELIQUIS, MOUNJARO, TRINTELLIX, JARDIANCE, CAMZYOS, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
